These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2375112)

  • 1. [Prognostic significance of nuclear DNA content in highly malignant thyroid tumors].
    Lukács G; Balázs G; Zs-Nagy I; Juhász F
    Wien Klin Wochenschr; 1990 Apr; 102(9):253-6. PubMed ID: 2375112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-existent anaplastic and well differentiated thyroid carcinomas: a nuclear DNA study.
    Wallin G; Bäckdahl M; Tallroth-Ekman E; Lundell G; Auer G; Löwhagen T
    Eur J Surg Oncol; 1989 Feb; 15(1):43-8. PubMed ID: 2465188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Flow cytometric DNA measurements of thyroid carcinomas].
    Tsuchiya A; Sekikawa K; Kimijima I; Suzuki S; Nihei M; Rokkaku Y; Abe R
    Gan No Rinsho; 1989 Jul; 35(8):886-90. PubMed ID: 2746864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochemical assessments of the nuclear DNA distribution pattern by means of image and flow cytometry in thyroid neoplasms and in non-neoplastic thyroid lesions. A comparative methodological study.
    Wallin G; Askensten U; Bäckdahl M; Grimelius L; Lundell G; Auer G
    Acta Chir Scand; 1989; 155(4-5):251-8. PubMed ID: 2800873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of DNA content in predicting the prognosis of thyroid carcinoma in an endemic iodine deficiency region.
    Onaran Y; Tezelman S; Gürel N; Terzioğlu T; Oğuz H; Tanakol R; Kapran Y
    Acta Chir Belg; 1999 Feb; 99(1):30-5. PubMed ID: 10090961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [DNA cytophotometry of oxyphilic thyroid tumors].
    Pilch H; Back W; Winter J
    Zentralbl Pathol; 1994 Feb; 139(6):433-6. PubMed ID: 8161492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear DNA measurements in squamous cell carcinoma of the lung: a guide for prognostic evaluation.
    Blöndal T; Bengtsson A
    Anticancer Res; 1981; 1(2):79-86. PubMed ID: 7051956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical meaning of DNA content in the long term behaviour of follicular thyroid tumours: a 12-year follow up.
    Lukács GL; Balázs G; Zs-Nagy I; Mikó T
    Eur J Surg; 1994 Aug; 160(8):417-23. PubMed ID: 7811827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nuclear DNA in neoplastic pathology of the thyroid gland].
    Sussi PL; Azzolina LS; Valerio A; Marchioretto F; Brazzarola P; Angeli G; Davì MV; Stival P; Finchi A; Francia G
    Chir Ital; 1994; 46(5):74-6. PubMed ID: 7788816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathological and clinical features of malignant thyroid tumors: classification, immunohistology, prognostic criteria].
    Schröder S
    Veroff Pathol; 1988; 130():1-159. PubMed ID: 3213226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nuclear DNA pattern of thyroid tumor].
    Tanaka H
    Nihon Jibiinkoka Gakkai Kaiho; 1992 Aug; 95(8):1239-46. PubMed ID: 1403317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA content in malignant salivary gland tumours.
    Monteiro LS; Palmeira C; Bento MJ; Lopes C
    Oral Dis; 2009 May; 15(4):295-301. PubMed ID: 19320959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The measurement of DNA content and ploidy analysis in thyroid neoplasms.
    McLeod MK
    Otolaryngol Clin North Am; 1990 Apr; 23(2):271-90. PubMed ID: 2186336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear DNA content and prognosis in Hürthle cell tumours of the thyroid gland.
    Wallin G; Bäckdahl M; Lundell G; Auer G; Löwhagen T
    Acta Chir Scand; 1988 Sep; 154(9):501-4. PubMed ID: 3201861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma.
    Raybaud H; Fortin A; Bairati I; Morency R; Monteil RA; Têtu B
    Int J Oral Maxillofac Surg; 2000 Feb; 29(1):36-41. PubMed ID: 10691142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear DNA measurements in follicular thyroid adenomas.
    Bäckdahl M; Wallin G; Askensten U; Auer G; Grimelius L; Löwhagen T
    Eur J Surg Oncol; 1989 Apr; 15(2):125-9. PubMed ID: 2703057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients.
    Volante M; Landolfi S; Chiusa L; Palestini N; Motta M; Codegone A; Torchio B; Papotti MG
    Cancer; 2004 Mar; 100(5):950-7. PubMed ID: 14983490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of DNA ploidy status in patients with rectal cancer.
    Berczi C; Bocsi J; Bartha I; Math J; Balazs G
    Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies of nuclear DNA content in benign and malignant thyroid lesions.
    Konarska L; Skierski J; Ellert A; Steinbrich J; Woźniak A; Kalczak M
    Acta Biochim Pol; 2001; 48(3):783-93. PubMed ID: 11833787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of nuclear DNA content in primary and metastatic papillary thyroid carcinoma.
    Bäckdahl M; Cohn K; Auer G; Forsslund G; Granberg PO; Lundell G; Löwhagen T; Willems JS; Zetterberg A
    Cancer Res; 1985 Jun; 45(6):2890-4. PubMed ID: 3986815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.